1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.66%
Negative revenue growth while OGI.TO stands at 4.80%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-35.70%
Negative gross profit growth while OGI.TO is at 1386.72%. Joel Greenblatt would examine cost competitiveness or demand decline.
20.21%
EBIT growth below 50% of OGI.TO's 49.36%. Michael Burry would suspect deeper competitive or cost structure issues.
20.21%
Operating income growth under 50% of OGI.TO's 49.36%. Michael Burry would be concerned about deeper cost or sales issues.
113.92%
Positive net income growth while OGI.TO is negative. John Neff might see a big relative performance advantage.
99.57%
EPS growth above 1.5x OGI.TO's 18.75%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
99.57%
Diluted EPS growth above 1.5x OGI.TO's 18.75%. David Dodd would see if there's a robust moat protecting these shareholder gains.
2.42%
Share reduction more than 1.5x OGI.TO's 281.68%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
2.42%
Diluted share reduction more than 1.5x OGI.TO's 281.68%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
81.64%
OCF growth at 75-90% of OGI.TO's 91.40%. Bill Ackman would demand better working capital management or cost discipline.
77.49%
FCF growth above 1.5x OGI.TO's 41.89%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
594.48%
5Y revenue/share CAGR 1.25-1.5x OGI.TO's 527.08%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
323.94%
Positive 3Y CAGR while OGI.TO is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-161.58%
Negative 10Y OCF/share CAGR while OGI.TO stands at 92.68%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-776.11%
Negative 5Y OCF/share CAGR while OGI.TO is at 98.17%. Joel Greenblatt would question the firm’s operational model or cost structure.
-559.39%
Negative 3Y OCF/share CAGR while OGI.TO stands at 98.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
284.96%
Net income/share CAGR above 1.5x OGI.TO's 68.94% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
43.41%
Below 50% of OGI.TO's 94.52%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-93.73%
Negative 3Y CAGR while OGI.TO is 93.39%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
5088.46%
10Y equity/share CAGR above 1.5x OGI.TO's 586.17%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
710.77%
Positive 5Y equity/share CAGR while OGI.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
47.80%
Positive short-term equity growth while OGI.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.47%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.35%
Inventory is declining while OGI.TO stands at 21.04%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.72%
Negative asset growth while OGI.TO invests at 7.29%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.42%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-8.47%
We’re deleveraging while OGI.TO stands at 148.73%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-34.39%
Our R&D shrinks while OGI.TO invests at 16.65%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.17%
We cut SG&A while OGI.TO invests at 7.21%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.